NGM BIOPHARMACEUTICALS INC Accumulated Other Comprehensive Income
NGM BIOPHARMACEUTICALS INC had Accumulated Other Comprehensive Income of $18.00 thousand as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2024-03-11
- 2023-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $18.00K.
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$78.00K.
- 2023-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$149.00K.
- 2023-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$97.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2023-12-31 | $18.00K 10-K · filed 2024-03-11 |
| 2023-09-30 | -$78.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | -$149.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$97.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$302.00K 10-K · filed 2024-03-11 |
| 2022-09-30 | -$915.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$1.08M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$677.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$129.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | -$11.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $5.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$18.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $15.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $137.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | -$55.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $25.00K 10-K · filed 2021-03-15 |
| 2019-09-30 | $99.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $102.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | -$45.00K 10-Q · filed 2019-05-16 |
| 2018-12-31 | -$267.00K 10-K · filed 2020-03-17 |